Pacer Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-313,362
| Closed | -$2.32M | – | 2385 |
|
|
2022
Q4 | $2.32M | Buy |
313,362
+82,066
| +35% | +$606K | 0.01% | 542 |
|
|
2022
Q3 | $2.29M | Sell |
231,296
-24,478
| -10% | -$242K | 0.02% | 424 |
|
|
2022
Q2 | $2.79M | Buy |
255,774
+41,987
| +20% | +$458K | 0.02% | 420 |
|
|
2022
Q1 | $2.42M | Buy |
213,787
+107,664
| +101% | +$1.22M | 0.02% | 557 |
|
|
2021
Q4 | $1.67M | Buy |
106,123
+35,511
| +50% | +$557K | 0.02% | 902 |
|
|
2021
Q3 | $1.21M | Buy |
70,612
+13,677
| +24% | +$234K | 0.02% | 797 |
|
|
2021
Q2 | $1.23M | Buy |
56,935
+23,812
| +72% | +$512K | 0.02% | 774 |
|
|
2021
Q1 | $498K | Buy |
33,123
+21,239
| +179% | +$319K | 0.01% | 1064 |
|
|
2020
Q4 | $156K | Buy |
11,884
+1,067
| +10% | +$14K | ﹤0.01% | 1276 |
|
|
2020
Q3 | $104K | Buy |
10,817
+5,641
| +109% | +$54.2K | ﹤0.01% | 1244 |
|
|
2020
Q2 | $59K | Sell |
5,176
-60
| -1% | -$684 | ﹤0.01% | 857 |
|
|
2020
Q1 | $60K | Sell |
5,236
-5,460
| -51% | -$62.6K | ﹤0.01% | 535 |
|
|
2019
Q4 | $176K | Sell |
10,696
-5,429
| -34% | -$89.3K | 0.01% | 1120 |
|
|
2019
Q3 | $214K | Buy |
16,125
+6,316
| +64% | +$83.8K | ﹤0.01% | 1086 |
|
|
2019
Q2 | $138K | Buy |
+9,809
| New | +$138K | ﹤0.01% | 1083 |
|
|
2018
Q4 | – | Sell |
-3,823
| Closed | -$88K | – | 1032 |
|
|
2018
Q3 | $88K | Buy |
+3,823
| New | +$88K | ﹤0.01% | 1104 |
|
|
2018
Q1 | – | Sell |
-1,125
| Closed | -$17K | – | 1132 |
|
|
2017
Q4 | $17K | Buy |
+1,125
| New | +$17K | ﹤0.01% | 1110 |
|